How amycretin works
Amycretin's weight-loss effect converges on the brain's appetite-control centers, especially the area postrema, a brain…
Two arms, one brainstem target
Amycretin's weight-loss effect converges on the brain's appetite-control centers, especially the area postrema, a brainstem region that senses hormones directly from the blood. Both its GLP-1 and amylin arms reach this satiety circuitry, then spread upward into the hypothalamus.
This unit traces the signal from receptor to behavior, shows where it acts in the brain and body, and explains why engaging two receptors at once should recruit a broader satiety network than either alone.
Key terms
Where the signal starts
The area postrema sits at the base of the brainstem and has an unusual property: its blood-brain barrier is leaky, so it can directly sense hormones circulating in the blood. It is densely packed with both amylin and GLP-1 receptors, making it a frontline satiety sensor that amycretin's two arms both engage.
The evidence for this circuit is strong for amylin. In rodents, selectively removing amylin receptors from the area postrema abolishes amylin's appetite-suppressing effect. That "necessary" result pins the amylin arm's core action to a specific brain structure, and amycretin's GLP-1 arm engages overlapping hindbrain circuitry.
AdvancedWhy a leaky barrier lets a big peptide act centrally
Most of the brain is shielded from blood-borne peptides by the blood-brain barrier, so a large peptide like amycretin cannot simply diffuse in everywhere. The area postrema is a circumventricular organ with leaky capillaries, so it samples the blood directly. That anatomical quirk is why a big, albumin-bound peptide can still act centrally: it does not need to cross the barrier, it acts where the barrier is already open.